Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative

BACKGROUND: Selection of systemic therapy for primary breast cancer is currently based on clinical biomarkers along with stage. Novel genomic tests are continuously being introduced as more precise tools for guidance of therapy, although they are often developed for specific patient subgroups. The S...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Surg
Main Authors: Rydén, L., Loman, N., Larsson, C., Hegardt, C., Vallon‐Christersson, J., Malmberg, M., Lindman, H., Ehinger, A., Saal, L. H., Borg, Å.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5817401/
https://ncbi.nlm.nih.gov/pubmed/29341157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bjs.10741
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados